Medication Experience Innovator MyMeds Named to The Observer’s List of Top Digital Health Start-ups in Nation
The Observer lauds MyMeds for addressing one of the biggest problems in healthcare – medication non-adherence.
Publication predicts heightened interest in the Minneapolis-based start-up at next week’s 37th Annual J.P. Morgan Healthcare Investment Conference in San Francisco
MINNEAPOLIS // Jan. 7, 2019 – Medication experience innovator MyMeds, a privately-held digital health company, today announced that it has been selected by THE OBSERVER as one of the nation’s twenty most promising health start-ups. The list, released today, highlights a selection of digital health and medical technology companies from across the United States that are transforming their respective fields. As today marks the kick-off of the 37th Annual J.P. Morgan Healthcare Investment Conference, the article posits that MyMeds will be one of the most in-demand companies to be attending the four-day gathering in San Francisco.
The Observer’s experts lauded MyMeds for addressing one of the health industry’s most critical – and solvable – concerns, medication non-adherence:
Some of our experts see MyMeds as the next generation of PillPack, the company Amazon swooped up for a jaw-dropping $1 billion in June of 2018. With a recently announced major partnership with the Mayo Clinic, this Minnesota-based start-up is addressing one of the biggest nagging problems in healthcare – medication non-adherence. By working with the complex system that links patients, doctors and pharmacies, MyMeds is arming care providers and patients (and their loved-ones) with an array of tools to make sure people take their meds. Many experts expect a sale to a big player, such as an Amazon or Walmart, in 2019 or 2020, which is why CEO Rajiv Shah’s dance card is a hot item in San Francisco.
The original Observer article can be found here.
“I was surprised and humbled to learn that MyMeds has been selected as one of the nation’s leading digital health start-ups by the Observer and its panel of venture capitalists and health experts,” said company CEO and Founder Dr. Rajiv R. Shah. “Medication non-adherence is a serious health issue and one that, unlike so many others across healthcare, is solvable. We just need tools for a better, more comprehensive and modern medication experience – and that is what we are trying to do with MyMeds. It’s truly rewarding to see that all of our hard work is being recognized at the top levels of the health industry.”
MyMeds modernizes the medication experience. Our mission is to transform the way people think about their meds. Founded by a doctor who believes that everyone can live healthy lives, and designed by a team of patients, pharmacists and physicians, MyMeds is the industry- recognized leader in the emerging field of medication adherence. MyMeds is the trusted partner of multiple large employers, health plans and PBMs.
For more information please visit: www.my-meds.com